New England Journal of Medicine Publishes Positive Results of Cefepime-Taniborbactam from Phase 3 CERTAIN-1 Study of Patients with Complicated Urinary Tract Infection

Malvern, PA, Parsippany, NJ, and Florence, Italy– February 20, 2024– Venatorx Pharmaceuticals, Melinta Therapeutics LLC (“Melinta”), and Menarini Group today announced that The New England Journal of Medicine (NEJM)...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials